Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan · Delayed Price · Currency is TWD 34.80
-0.90 (-2.52%)
May 8, 2026, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 4.49 billion as of May 8, 2026. Its market cap has decreased by -22.63% in one year.
Market Cap
4.49B
Enterprise Value
3.46B
Revenue
67.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.80
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has decreased from 4.86B to 4.49B, a decrease of -7.48%. That is a compound annual growth rate of -1.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 4.49B | -32.91% |
| Dec 31, 2025 | 6.70B | -1.89% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
| Feb 22, 2022 | 4.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panion & Bf Biotech | 5.52B |
| UnicoCell Biomed | 5.30B |
| Steminent Biotherapeutics | 5.00B |
| Medigen Biotechnology | 4.60B |
| Senhwa Biosciences | 4.59B |
| OBI Pharma | 4.48B |
| ACRO Biomedical | 4.35B |
| Formosa Pharmaceuticals | 4.06B |